(Q53274538)

12 May 2018

title

Problems associated with biological markers of Alzheimer's disease. (English)

1 reference

12 May 2018

author name string

H J Frey

1

1 reference

12 May 2018

K M Mattila

2

1 reference

12 May 2018

M A Korolainen

3

1 reference

12 May 2018

T Pirttilä

4

1 reference

12 May 2018

publication date

1 December 2005

1 reference

12 May 2018

published in

Neurochemical Research

1 reference

12 May 2018

volume

30

1 reference

12 May 2018

issue

12

1 reference

12 May 2018

page(s)

1501-1510

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s11064-005-8827-7

exact match

0 references

cites work

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-8827-7

Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-8827-7

Extraneuronal manifestations of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-8827-7

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-8827-7

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-8827-7

Correlation between rates of brain atrophy and cognitive decline in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-005-8827-7

Biomarkers in Alzheimer's disease?

21 January 2018

1 reference

12 December 2020

Protein carbonyl groups as biomarkers of oxidative stress.

1 reference

12 December 2020

Peripheral biomarkers of oxidative damage in Alzheimer's disease: the road ahead.

1 reference

12 December 2020

Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease

1 reference

12 December 2020

Cytochrome c oxidase is decreased in Alzheimer's disease platelets

1 reference

12 December 2020

Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.

1 reference

12 December 2020

Comparison of methods for analysis of CSF proteins in patients with Alzheimer's disease.

1 reference

12 December 2020

Application of proteomics technologies in the investigation of the brain

1 reference

12 December 2020

Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis

1 reference

12 December 2020

Increased plasma amyloid beta protein 1-42 levels in Down syndrome

1 reference

12 December 2020

Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

1 reference

12 December 2020

Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investig

1 reference

12 December 2020

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

12 December 2020

Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions

1 reference

12 December 2020

The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.

1 reference

12 December 2020

Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma

1 reference

12 December 2020

The use of proteomics for the assessment of clinical samples in research

1 reference

12 December 2020

Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals

1 reference

12 December 2020

The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?

1 reference

12 December 2020

Alzheimer neuropathologic alterations in aged cognitively normal subjects.

1 reference

12 December 2020

Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome

1 reference

12 December 2020

Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation.

1 reference

12 December 2020

Isoelectric focusing and two-dimensional gel electrophoresis in plasma and cerebrospinal fluid from patients with dementia.

1 reference

12 December 2020

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

12 December 2020

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1 reference

12 December 2020

Two-dimensional analysis of qualitative and quantitative changes in blood cell proteins in Alzheimer's disease: search for extraneuronal markers

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

12 December 2020

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

12 December 2020

Isoelectric focusing in immobilized pH gradients: Principle, methodology and some applications

1 reference

12 December 2020

Abnormal expression of actin in lymphocytes of Alzheimer's disease and Down's syndrome patients

1 reference

12 December 2020

CSF markers for incipient Alzheimer's disease

1 reference

12 December 2020

Two-dimensional electrophoretic analysis of the protein spectrum of human brain structures in schizophrenia and senile dementia of the Alzheimer type

1 reference

12 December 2020

1 reference

12 December 2020

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

12 December 2020

Alzheimer's disease. A metabolic systems degeneration?

1 reference

12 December 2020

Neuropathological stageing of Alzheimer-related changes

1 reference

12 December 2020

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

1 reference

12 December 2020

Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.

1 reference

12 December 2020

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

1 reference

12 December 2020

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease.

1 reference

12 December 2020

Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases

1 reference

12 December 2020

Research evaluation and prospective diagnosis of dementia with Lewy bodies.

1 reference

12 December 2020

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

1 reference

12 December 2020

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

12 December 2020

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

1 reference

12 December 2020

Proteomic analysis of protein oxidation in Alzheimer's disease brain

1 reference

12 December 2020

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF

1 reference

12 December 2020

Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

1 reference

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

12 December 2020

Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry

1 reference

12 December 2020

Alzheimer brain proteins investigated by two-dimensional gel electrophoresis with immobilized pH gradients in the first dimension.

1 reference

12 December 2020

Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain

1 reference

12 December 2020

Proteomics in gerontological research

1 reference

12 December 2020

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

12 December 2020

Clinicopathological analysis of dementia disorders in the elderly.

1 reference

12 December 2020

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

12 December 2020

Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.

1 reference

12 December 2020

Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease.

1 reference

12 December 2020

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

12 December 2020

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

1 reference

12 December 2020

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

12 December 2020

Altered blood-brain-barrier function in Alzheimer's disease?

1 reference

12 December 2020

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins.

1 reference

12 December 2020

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

12 December 2020

Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons

1 reference

12 December 2020

Sulfated glycosaminoglycans: a common constituent of all amyloids?

1 reference

12 December 2020

Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain

1 reference

12 December 2020

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

1 reference

12 December 2020

High resolution two-dimensional electrophoresis of proteins

1 reference

12 December 2020

Applicability of semi-automatic segmentation for volumetric analysis of brain lesions.

1 reference

12 December 2020

Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

1 reference

12 December 2020

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

1 reference

12 December 2020

Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease.

1 reference

12 December 2020

Identification of oxidized plasma proteins in Alzheimer's disease

1 reference

12 December 2020

Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.

1 reference

12 December 2020

Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.

1 reference

12 December 2020

Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein

1 reference

12 December 2020

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

12 December 2020

Two-dimensional gel electrophoresis of human brain proteins. I. Technique and nomenclature of proteins.

1 reference

12 December 2020

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

1 reference

12 December 2020

Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease

1 reference

12 December 2020

Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease

1 reference

12 December 2020

Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease.

1 reference

12 December 2020

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

12 December 2020

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

12 December 2020

Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease

1 reference

12 December 2020

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

1 reference

12 December 2020

Apolipoprotein E, amyloid, and Alzheimer disease

1 reference

12 December 2020

10.1007/S11064-005-8827-7

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018